Kevin Buehler - 03 Jun 2026 Form 4 Insider Report for PRECISION BIOSCIENCES INC (DTIL)

Source evidence Original filing metadata and source links for verification. 4 source fields
SEC form
4
Accepted by SEC
05 Jun 2026, 07:35:23 UTC
Prior SEC filing
22 May 2026
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/ Dario Scimeca, Attorney-in-Fact for Kevin Buehler

Key filing fact

Kevin Buehler filed Form 4 for PRECISION BIOSCIENCES INC (DTIL) on 05 Jun 2026.

Key facts

  • This page summarizes Kevin Buehler's Form 4 filing for PRECISION BIOSCIENCES INC (DTIL).
  • 1 reported transaction and 1 derivative row are listed below.
  • Accepted by SEC: 05 Jun 2026, 07:35.

Change

  • Previous filing in this sequence was filed on 22 May 2026.
  • Current net transaction value: $0.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001792722 Primary reporting owner

Buehler Kevin

Relationship
Director
Address
C/O PRECISION BIOSCIENCES, INC., 302 E. PETTIGREW ST, SUITE A-100, DURHAM
Signature
/s/ Dario Scimeca, Attorney-in-Fact for Kevin Buehler
Signature date
05 Jun 2026

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

DTIL transaction Derivative

Restricted Stock Units

Award

Transaction value
Shares
+20,979
Change %
Price
$0.000000*
Shares after
20,979
Date
03 Jun 2026
Ownership
Direct
Underlying class
Common Stock
Underlying amount
20,979
Exercise price
Footnotes
F1, F2
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 2 footnotes

Footnote F1

Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Common Stock.

Footnote F2

The RSUs vest on the earlier to occur of (i) June 3, 2027 and (ii) the day immediately prior to the Issuer's next annual meeting of stockholders following the grant date, in either case, subject to the Reporting Person's continued service to the Issuer through the applicable vesting date.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .